The Value of Innovation in Oncology - Recognizing Emerging Benefits Over Time Executive Summary

Biopharmaceutical Companies Driving Personalized Medicine

Research in Pennsylvania

Sens. Portman, Cornyn, et al letter

Morning Consult - PhRMA National Poll - 5.1.15

PhRMA ITC Testimony - April 23, 2015

Clinical Trials Awareness Week Toolkit

PhRMA Statement on First FDA Approval of A Biosimilar Product

PhRMA supports a science-based, transparent implementation of the BPCIA biosimilars pathway.

2005 - 2015: A Decade of Innovation In Rare Diseases

Researching Hepatitis C Medicines: Setbacks and Stepping Stones


Subscribe to RSS - Innovation